519
Views
10
CrossRef citations to date
0
Altmetric
Review Article

A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q − myelodysplastic syndromes

&
Pages 779-788 | Received 24 Jun 2011, Accepted 09 Sep 2011, Published online: 25 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Abdallah Abou Zahr, Ehab Saad Aldin, Rami S Komrokji & Amer M Zeidan. (2015) Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes. Journal of Blood Medicine 6, pages 1-16.
Read now

Articles from other publishers (9)

Qing Nian, Jingwei Li, ZhongYu Han, Qi Liang, Maoyu Liu, Chan Yang, Fernando Rodrigues-Lima, Tao Jiang, Liyun Zhao, Jinhao Zeng, Chi Liu & Jianyou Shi. (2022) SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression. Biomedicine & Pharmacotherapy 153, pages 113519.
Crossref
Ioannis A. Voutsadakis. (2022) Loss of genes in chromosome arms 5q and 16q in breast cancer. Breast Disease 41:1, pages 331-341.
Crossref
Sung-Yong Kim. (2020) Lenalidomide for the Treatment of Myelodysplastic Syndrome. The Korean Journal of Medicine 95:2, pages 74-77.
Crossref
Ota Fuchs. (2019) Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 51-78.
Crossref
Maximilian Stahl & Amer M. Zeidan. (2017) Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications. Cancer 123:10, pages 1703-1713.
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology 5-58 5-61 .
Hani NakhoulJiangwei KeXiang ZhouWenjuan LiaoShelya X. ZengHua Lu. (2014) Ribosomopathies: Mechanisms of Disease. Clinical Medicine Insights: Blood Disorders 7, pages CMBD.S16952.
Crossref
Amer M. Zeidan, Yuliya Linhares & Steven D. Gore. (2013) Current therapy of myelodysplastic syndromes. Blood Reviews 27:5, pages 243-259.
Crossref
Rastislav Horos & Marieke von Lindern. (2012) Molecular mechanisms of pathology and treatment in D iamond B lackfan A naemia . British Journal of Haematology 159:5, pages 514-527.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.